|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
0.70/-0.94
|
企業價值
125.75M
|
資產負債 |
每股賬面淨值
4.77
|
現金流量 |
現金流量率
0.13
|
損益表 |
收益
380.79M
|
每股收益
2.82
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/14 11:57 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder. |